Immunoglobulin-Driven Activation of the Complement Cascade is a Critical Determinant of PAH Initiation and Progression
免疫球蛋白驱动的补体级联激活是 PAH 发生和进展的关键决定因素
基本信息
- 批准号:10686929
- 负责人:
- 金额:$ 47万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-08-01 至 2025-06-30
- 项目状态:未结题
- 来源:
- 关键词:AreaArthritisAutoantibodiesAutoimmuneAutoimmune DiseasesBindingBiological MarkersBlood VesselsCellsChimeric ProteinsClinicalComplementComplement 3dComplement ActivationComplement InactivatorsDataDepositionDiagnosisDiseaseEpitope spreadingEpitopesGoalsHumanHypertensionHypoxiaImmuneImmune responseImmunoglobulin GImmunoglobulinsInflammationInflammatoryInjuryKidney DiseasesLife ExpectancyLungMalignant NeoplasmsMediatingNatural ImmunityOutcomePathogenesisPathway AnalysisPathway interactionsPatientsPlasmaProcessPrognostic FactorPublishingPulmonary Heart DiseasePulmonary HypertensionResearch PersonnelRodentRoleSignal TransductionSterilityStimulusTestingTimeVascular remodelingX-Ray Computed Tomographyarmcomplement systemdiagnostic biomarkerefficacy testingin vivolung vascular injurynatural antibodiesneoantigensnovelpulmonary arterial pressurepulmonary vascular disorderpulmonary vascular remodelingrecruitsingle photon emission computed tomographytargeted deliverytargeted treatmenttherapeutic targettissue injuryvascular inflammationvascular injury
项目摘要
There is convincing evidence for both inflammatory and autoimmune phenomena to be involved in the
pathogenesis of PAH. However, both the triggering and the disease sustaining mechanisms remain elusive.
Based on emerging evidence in other diseases, including arthritis, kidney disease, and cancer, generated
by Co-Investigators on this project, it has become clear that the Complement system, when dysregulated,
can become a potent instigator of inflammation-driven tissue injury. Our recently published data
demonstrated, we believe for the first time, that the immunoglobulin-driven activation of the complement
cascade, specifically its alternative pathway, in the pulmonary perivascular areas is a critical mechanism
initiating pro-inflammatory and pro-proliferative processes in experimental hypoxic PH (a form of “sterile
inflammation”). We also demonstrated that the activated complement cascade and immunoglobulin G (IgG)
deposition are persistent determinants of the disease. The present proposal builds on these findings and
comprises both mechanistic and translational arms. In Aim 1 we will evaluate the role of immunoglobulins
and complement in initiation of pro-inflammatory processes in PH. In Aim 2 we will evaluate the role of
immunoglobulins and complement in the sustained progression of vascular injury and the disease process. In
a potentially highly translational Aim 3 we will test the efficacy of targeted (local) complement inhibition in
experimental PH using a novel complement inhibitor, human fusion protein termed TT32, which can be used
to target local activated complement signaling.
有令人信服的证据表明,炎症和自身免疫现象都参与了这一过程。
PAH的发病机制。然而,触发和疾病维持机制仍然难以捉摸。
基于其他疾病的新证据,包括关节炎,肾脏疾病和癌症,
由该项目的共同研究者,很明显,补体系统,当失调时,
可能成为炎症驱动的组织损伤的有力煽动者。我们最近公布的数据
我们相信,这是第一次证明,免疫球蛋白驱动的补体激活
级联反应,特别是其旁路途径,在肺血管周围地区是一个关键机制
在实验性缺氧PH(一种“无菌”形式)中启动促炎和促增殖过程
炎症”)。我们还证明了激活的补体级联和免疫球蛋白G(IgG)
沉积是疾病的持久决定因素。本建议以这些调查结果为基础,
包括机械臂和平移臂。在目标1中,我们将评估免疫球蛋白的作用
在目的2中,我们将评估
免疫球蛋白和补体在血管损伤和疾病过程的持续进展中的作用。在
一个潜在的高度翻译的目标3,我们将测试靶向(局部)补体抑制的功效,
实验PH使用一种新的补体抑制剂,人融合蛋白TT32,它可以使用
靶向局部激活的补体信号传导。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kurt R. Stenmark其他文献
Glycolytic Metabolism of Fibrocytes Derived from Distal Pulmonary Artery Wall of Chronic Hypoxia-Induced Pulmonary Hypertensive Neonatal Calves Exhibit Increased Oxidative Stress
- DOI:
10.1016/j.freeradbiomed.2012.10.157 - 发表时间:
2012-11-01 - 期刊:
- 影响因子:
- 作者:
Lydie Plecita;Petr Jezek;Min Li;Amanda R. Flockton;Michael E. Yeager;Kurt R. Stenmark - 通讯作者:
Kurt R. Stenmark
Kolorado Üniversitesi Tip Fakültesi, Tip Bölümü, Translasyonel Akciğer Araştirma Programi, Aurora, Kolorado, ABD;
Kolorado Üniversitesi Tip Fakültesi、Tip Bölümü、Translasyonel Akciğer Araştirma Programi、Aurora、Kolorado、ABD;
- DOI:
- 发表时间:
2014 - 期刊:
- 影响因子:0
- 作者:
Rubin M. Tuder;Stephen L. Archer;Peter Dorfmüller;Serpil C. Erzurum;Christophe Guignabert;Evangelos D. Michelakis;Marlene Rabinovitch;Ralph T. Schermuly;Kurt R. Stenmark;NW Morrell - 通讯作者:
NW Morrell
Characterization of pulmonary arterial stiffness using cardiac MRI
- DOI:
10.1007/s10554-023-02989-6 - 发表时间:
2023-10-30 - 期刊:
- 影响因子:1.500
- 作者:
Michael T. Cain;Michal Schäfer;Sarah Park;Alex J. Barker;Daniel Vargas;Kurt R. Stenmark;Yen-Rei A. Yu;Todd M. Bull;D. Dunbar Ivy;Jordan R.H. Hoffman - 通讯作者:
Jordan R.H. Hoffman
Clasificación funcional de la hipertensión pulmonar en niños: informe del task force pediátrico del Pulmonary Vascular Research Institute (PVRI), Panamá 2011
血管研究所 (PVRI),巴拿马 2011 年
- DOI:
10.1016/s0120-5633(12)70156-0 - 发表时间:
2012 - 期刊:
- 影响因子:0
- 作者:
Astrid E. Lammers;Ian Adatia;M. D. Cerro;G. Diaz;Alexandra Heath Freudenthal;F. Freudenthal;S. Harikrishnan;Dunbar Ivy;Antonio Augusto Lopes;J. U. Raj;Julio Sandoval;Kurt R. Stenmark;Sheila G. Haworth - 通讯作者:
Sheila G. Haworth
Consenso sobre la clasificación de la enfermedad vascular pulmonar hipertensiva en niños: Reporte del task force pediátrico del Pulmonary Vascular Research Institute (PVRI) Panamá 2011
Consenso sobre la clasificación de la enfermedad vasural pulmonar hipertensiva en niños: Reporte del 工作组儿科肺血管研究所 (PVRI) 巴拿马 2011
- DOI:
10.1016/s0120-5633(12)70157-2 - 发表时间:
2012 - 期刊:
- 影响因子:0
- 作者:
M. D. Cerro;Steven H. Abman;G. Diaz;Alexandra Heath Freudenthal;F. Freudenthal;S. Harikrishnan;Sheila G. Haworth;D. Ivy;Antonio Augusto Lopes;J. U. Raj;Julio Sandoval;Kurt R. Stenmark;Ian Adatia;Astrid E. Lammers - 通讯作者:
Astrid E. Lammers
Kurt R. Stenmark的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kurt R. Stenmark', 18)}}的其他基金
Complement Mediated Remodeling in Pulmonary Vascular Disease
肺血管疾病中补体介导的重塑
- 批准号:
10686922 - 财政年份:2020
- 资助金额:
$ 47万 - 项目类别:
Immunoglobulin-Driven Activation of the Complement Cascade is a Critical Determinant of PAH Initiation and Progression
免疫球蛋白驱动的补体级联激活是 PAH 发生和进展的关键决定因素
- 批准号:
10470735 - 财政年份:2020
- 资助金额:
$ 47万 - 项目类别:
Complement Mediated Remodeling in Pulmonary Vascular Disease
肺血管疾病中补体介导的重塑
- 批准号:
10470731 - 财政年份:2020
- 资助金额:
$ 47万 - 项目类别:
Complement Mediated Remodeling in Pulmonary Vascular Disease
肺血管疾病中补体介导的重塑
- 批准号:
10224327 - 财政年份:2020
- 资助金额:
$ 47万 - 项目类别:
Immunoglobulin-Driven Activation of the Complement Cascade is a Critical Determinant of PAH Initiation and Progression
免疫球蛋白驱动的补体级联激活是 PAH 发生和进展的关键决定因素
- 批准号:
10224331 - 财政年份:2020
- 资助金额:
$ 47万 - 项目类别:
Complement Mediated Remodeling in Pulmonary Vascular Disease
肺血管疾病中补体介导的重塑
- 批准号:
10024460 - 财政年份:2020
- 资助金额:
$ 47万 - 项目类别:
Crosstalk Between Metabolism and Inflammation in Pulmonary Hypertension
肺动脉高压代谢与炎症之间的串扰
- 批准号:
8800338 - 财政年份:2014
- 资助金额:
$ 47万 - 项目类别:
相似国自然基金
Autoimmune diseases therapies: variations on the microbiome in rheumatoid arthritis
- 批准号:31171277
- 批准年份:2011
- 资助金额:60.0 万元
- 项目类别:面上项目
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data
- 批准号:31070748
- 批准年份:2010
- 资助金额:34.0 万元
- 项目类别:面上项目
相似海外基金
Do autoantibodies to aberrantly glycosylated MUC1 drive extra-articular rheumatoid arthritis, and can GSK assets prevent driver antigen formation?
针对异常糖基化 MUC1 的自身抗体是否会导致关节外类风湿性关节炎,GSK 资产能否阻止驱动抗原形成?
- 批准号:
MR/Y022947/1 - 财政年份:2024
- 资助金额:
$ 47万 - 项目类别:
Research Grant
Rheumatoid Arthritis-Related Autoantibodies, Articular Inflammation, and RA-Associated Interstitial Lung Disease
类风湿关节炎相关自身抗体、关节炎症和 RA 相关间质性肺病
- 批准号:
10491725 - 财政年份:2021
- 资助金额:
$ 47万 - 项目类别:
The Mechanism of Articular Destruction by Autoantibodies Related with Rheumatoid Arthritis
类风湿性关节炎相关自身抗体破坏关节的机制
- 批准号:
21K16723 - 财政年份:2021
- 资助金额:
$ 47万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Rheumatoid Arthritis-Related Autoantibodies, Articular Inflammation, and RA-Associated Interstitial Lung Disease
类风湿关节炎相关自身抗体、关节炎症和 RA 相关间质性肺病
- 批准号:
10647761 - 财政年份:2021
- 资助金额:
$ 47万 - 项目类别:
Rheumatoid Arthritis-Related Autoantibodies, Articular Inflammation, and RA-Associated Interstitial Lung Disease
类风湿关节炎相关自身抗体、关节炎症和 RA 相关间质性肺病
- 批准号:
10207955 - 财政年份:2021
- 资助金额:
$ 47万 - 项目类别:
The interrelationship of autoantibodies in patients with rheumatoid arthritis – rheumatoid factors revisited
类风湿关节炎患者自身抗体的相互关系与类风湿因子的再探讨
- 批准号:
399561834 - 财政年份:2018
- 资助金额:
$ 47万 - 项目类别:
Research Grants
PAD2 and PAD4 in Citrullination, Autoantibodies, and Rheumatoid Arthritis
PAD2 和 PAD4 在瓜氨酸化、自身抗体和类风湿关节炎中的作用
- 批准号:
8817244 - 财政年份:2014
- 资助金额:
$ 47万 - 项目类别:
PAD2 and PAD4 in Citrullination, Autoantibodies, and Rheumatoid Arthritis
PAD2 和 PAD4 在瓜氨酸化、自身抗体和类风湿关节炎中的作用
- 批准号:
8618032 - 财政年份:2014
- 资助金额:
$ 47万 - 项目类别:
PAD2 and PAD4 in Citrullination, Autoantibodies, and Rheumatoid Arthritis
PAD2 和 PAD4 在瓜氨酸化、自身抗体和类风湿关节炎中的作用
- 批准号:
9017936 - 财政年份:2014
- 资助金额:
$ 47万 - 项目类别:
PAD2 and PAD4 in Citrullination, Autoantibodies, and Rheumatoid Arthritis
PAD2 和 PAD4 在瓜氨酸化、自身抗体和类风湿关节炎中的作用
- 批准号:
9235228 - 财政年份:2014
- 资助金额:
$ 47万 - 项目类别: